Biotech moves fast. Your CRO partner should too.

日期:

活动简介:

Meet Novotech to discuss capital-efficient early clinical pathways and scalable execution across APAC, North America, and Europe.

Start first-in-human in Australia

  • Rapid study start-up
  • No IND required
  • Data accepted by global regulators

Expand into China at the right time

  • Accelerate recruitment
  • Build larger, more representative datasets
  • Align with local regulatory requirements

Continue globally without changing course

  • Multi-region studies across the US, Europe, and APAC
  • Consistent teams from early phase through later phases
  • Regulatory alignment across regions

Proven experience: 4,450+ trials, 7,260+ trial sites, 4,950+ investigators, 50+ countries, 60+ drugs to market.

Stop by Booth 5443 or request a meeting via the form on this page to discover how Novotech helps biotech sponsors to start faster.

本次活动已圆满结束

诚挚感谢您在本次活动中对Novotech(诺为泰)的深切关注。活动虽已落幕,但我们的专家团队仍将持续为申办方提供全方位支持,其中涵盖临床开发的各个阶段。

是否有任何疑问,或希望与我们开展进一步洽谈?

欢迎咨询临床开发专家

参会人员

Novotech

Judith Ng-Cashin博士

Novotech
首席医学官
诺为泰

Barry Murphy

诺为泰
首席商务官
Novotech

Marina Mullins

Novotech
治疗策略团队负责人
Novotech

Elaina Haeuber

Novotech
全球项目管理高级副总裁